Vitamin K occurs in the natural world in several forms, including a plant form, phylloquinone (PK), and a bacterial form, menaquinones (MKs). In many species, including humans, PK is a minor constituent of hepatic vitamin K content, with most hepatic vitamin K content comprising long-chain MKs. Menaquinone-4 (MK-4) is ubiquitously present in extrahepatic tissues, with particularly high concentrations in the brain, kidney and pancreas of humans and rats(1-3). It has consistently been shown that PK is endogenously converted to MK-4 (refs 4-8). This occurs either directly within certain tissues or by interconversion to menadione (K-3), followed by prenylation to MK-4 (refs 9-12). No previous study has sought to identify the human enzyme responsible for MK-4 biosynthesis. Previously we provided evidence for the conversion of PK and K3 into MK-4 in mouse cerebra(13). However, the molecular mechanisms for these conversion reactions are unclear. Here we identify a human MK-4 biosynthetic enzyme. We screened the human genome database for prenylation enzymes and found UbiA prenyltransferase containing 1 (UBIAD1), a human homologue of Escherichia coli prenyltransferase menA. We found that short interfering RNA against the UBIAD1 gene inhibited the conversion of deuterium-labelled vitamin K derivatives into deuterium-labelled-MK-4 (MK-4-d(7)) in human cells. We confirmed that the UBIAD1 gene encodes an MK-4 biosynthetic enzyme through its expression and conversion of deuterium-labelled vitamin K derivatives into MK-4-d(7) in insect cells infected with UBIAD1 baculovirus. Converted MK-4-d(7) was chemically identified by H-2-NMR analysis. MK-4 biosynthesis by UBIAD1 was not affected by the vitamin K antagonist warfarin. UBIAD1 was localized in endoplasmic reticulum and ubiquitously expressed in several tissues of mice. Our results show that UBIAD1 is a human MK-4 biosynthetic enzyme; this identification will permit more effective decisions to be made about vitamin K intake and bone health.
机构:
UCL Inst Ophthalmol, London, EnglandUCL Inst Ophthalmol, London, England
Evans, Cerys J.
Dudakova, Lubica
论文数: 0引用数: 0
h-index: 0
机构:
Charles Univ Prague, Fac Med 1, Dept Paediat & Adolescent Med, Res Unit Rare Dis, Ke Karlovu 2, Prague 12808 2, Czech Republic
Gen Univ Hosp Prague, Ke Karlovu 2, Prague 12808 2, Czech RepublicUCL Inst Ophthalmol, London, England
Dudakova, Lubica
Skalicka, Pavlina
论文数: 0引用数: 0
h-index: 0
机构:
Charles Univ Prague, Fac Med 1, Dept Paediat & Adolescent Med, Res Unit Rare Dis, Ke Karlovu 2, Prague 12808 2, Czech Republic
Gen Univ Hosp Prague, Ke Karlovu 2, Prague 12808 2, Czech Republic
Charles Univ Prague, Fac Med 1, Dept Ophthalmol, Prague, Czech RepublicUCL Inst Ophthalmol, London, England
Skalicka, Pavlina
Mahelkova, Gabriela
论文数: 0引用数: 0
h-index: 0
机构:
Charles Univ Prague, Fac Med 2, Dept Ophthalmol, Prague, Czech Republic
Motol Univ Hosp, Prague, Czech RepublicUCL Inst Ophthalmol, London, England
Mahelkova, Gabriela
Horinek, Ales
论文数: 0引用数: 0
h-index: 0
机构:
Gen Univ Hosp Prague, Ke Karlovu 2, Prague 12808 2, Czech Republic
Charles Univ Prague, Fac Med 1, Dept Endocrinol & Metab, Dept Med 3, Prague, Czech Republic
Charles Univ Prague, Fac Med 1, Inst Biol & Human Genet, Prague, Czech RepublicUCL Inst Ophthalmol, London, England
Horinek, Ales
Hardcastle, Alison J.
论文数: 0引用数: 0
h-index: 0
机构:
UCL Inst Ophthalmol, London, EnglandUCL Inst Ophthalmol, London, England
Hardcastle, Alison J.
Tuft, Stephen J.
论文数: 0引用数: 0
h-index: 0
机构:
Moorfields Eye Hosp, London, EnglandUCL Inst Ophthalmol, London, England
Tuft, Stephen J.
Liskova, Petra
论文数: 0引用数: 0
h-index: 0
机构:
Charles Univ Prague, Fac Med 1, Dept Paediat & Adolescent Med, Res Unit Rare Dis, Ke Karlovu 2, Prague 12808 2, Czech Republic
Gen Univ Hosp Prague, Ke Karlovu 2, Prague 12808 2, Czech Republic
Charles Univ Prague, Fac Med 1, Dept Ophthalmol, Prague, Czech RepublicUCL Inst Ophthalmol, London, England